Narasin

2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid

VHKXXVVRRDYCIK-CWCPJSEDSA-N CHEBI:183815 0 Reactome links 3 studies

3 Observed studies

3 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: VHKXXVVRRDYCIK-CWCPJSEDSA-N
InChI Key: VHKXXVVRRDYCIK-CWCPJSEDSA-N
IUPAC name: 2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
Preferred name: Narasin
INN name: —
Synonym: —
ChEBI: CHEBI:183815

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles